Pirfenidone Capsule 267 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 267 mg
Reference Brands: Esbriet (USA/EU)
Category: Respiratory Disorder
Tablet contains pirfenidone. It is used to treat idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a type of lung disorder in which tissues of the lungs become scarred and inflamed, resulting in breathing difficulties. This medicine should not be used if you have severe liver disorders, severe kidney disorders, if you are taking fluvoxamine (treats depression and obsessive compulsive disorder), or if you are allergic to any of the ingredients of this medicine.
Product Description:
This medicine is not recommended for adolescents and children under the age of 18. Avoid smoking as it may reduce the efficacy of the Pirfenex Tablet. Avoid exposure to sunlight, including sunlamps. Use sunscreen daily and cover your head, legs, and arms to reduce exposure to sunlight. Do not drink grapefruit juice while taking this medicine. Taking this medicine can cause weight loss.
Pirfenidone Capsule — third party manufacturing & bulk supply
Pirfenidone Capsule 267 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Pirfenidone Capsule listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Pirfenidone Capsule →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Pirfenidone is used to treat idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung disease. It helps slow the decline in lung function by reducing fibrosis and inflammation in lung tissue.
Pirfenidone is a small-molecule antifibrotic and anti-inflammatory agent. Its chemical name is 5-methyl-1-phenyl-2-(1H)-pyridone.
Pirfenidone is marketed under the trade name Esbriet in the USA, EU, and UK. Generic pirfenidone is also available in several EU countries under different brand names.
Pirfenidone was originally developed and is marketed by Roche under the brand name Esbriet. Generic versions are manufactured by multiple pharmaceutical companies.
The generic name is Pirfenidone.
The brand name is Esbriet. Generic brands are also available depending on the region.
Pirfenidone is manufactured in various countries including the USA and EU member states by Roche and approved generic manufacturers.
Related Products
Salmeterol Xinafoate
Strength:
25 µg, 50 µg
Form: Inhalation
Reference Brands: Serevent (USA/LATAM/EU)
View Details
Formoterol Fumarate
Strength:
12 µg
Form: Inhalation
Reference Brands: Foradil (USA/LATAM), Oxis (India)
View Details
Ethionamide
Strength:
250 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Olodaterol
Strength:
2.5 mcg
Form: Inhalation solution
Reference Brands: Striverdi Respimat (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
